1. Home
  2. SCPH vs FINW Comparison

SCPH vs FINW Comparison

Compare SCPH & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • FINW
  • Stock Information
  • Founded
  • SCPH 2013
  • FINW 1999
  • Country
  • SCPH United States
  • FINW United States
  • Employees
  • SCPH N/A
  • FINW N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • FINW Commercial Banks
  • Sector
  • SCPH Health Care
  • FINW Finance
  • Exchange
  • SCPH Nasdaq
  • FINW Nasdaq
  • Market Cap
  • SCPH 173.6M
  • FINW 207.1M
  • IPO Year
  • SCPH 2017
  • FINW 2021
  • Fundamental
  • Price
  • SCPH $4.51
  • FINW $15.57
  • Analyst Decision
  • SCPH Strong Buy
  • FINW Buy
  • Analyst Count
  • SCPH 3
  • FINW 4
  • Target Price
  • SCPH $14.00
  • FINW $20.75
  • AVG Volume (30 Days)
  • SCPH 261.6K
  • FINW 78.2K
  • Earning Date
  • SCPH 08-13-2025
  • FINW 07-24-2025
  • Dividend Yield
  • SCPH N/A
  • FINW N/A
  • EPS Growth
  • SCPH N/A
  • FINW N/A
  • EPS
  • SCPH N/A
  • FINW 0.91
  • Revenue
  • SCPH $41,982,000.00
  • FINW $72,056,000.00
  • Revenue This Year
  • SCPH $108.95
  • FINW $38.17
  • Revenue Next Year
  • SCPH $73.83
  • FINW $18.44
  • P/E Ratio
  • SCPH N/A
  • FINW $17.02
  • Revenue Growth
  • SCPH 138.10
  • FINW 7.66
  • 52 Week Low
  • SCPH $1.94
  • FINW $10.32
  • 52 Week High
  • SCPH $5.65
  • FINW $20.94
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 60.01
  • FINW 60.72
  • Support Level
  • SCPH $3.83
  • FINW $15.23
  • Resistance Level
  • SCPH $4.18
  • FINW $16.23
  • Average True Range (ATR)
  • SCPH 0.17
  • FINW 0.54
  • MACD
  • SCPH -0.02
  • FINW 0.14
  • Stochastic Oscillator
  • SCPH 76.60
  • FINW 72.73

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

Share on Social Networks: